Vimarsana
Biggest News Aggregation in the World

Page 22 - Ancer Immunotherapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ancer Immunotherapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ancer Immunotherapy Today - Breaking & Trending Today

Administering immunotherapy drug before surgery for oral cavity cancer did not increase complications - Vimarsana News

Administering immunotherapy drug before surgery for oral cavity cancer did not increase complications

A University of Cincinnati study found administering an immunotherapy drug before surgery for oral cavity cancer did not lead to increased rates of complications during and after surgery.

Stanford spinout 3T Bio snags $40M for immunotherapies targeted to solid tumors - Vimarsana News

Stanford spinout 3T Bio snags $40M for immunotherapies targeted to solid tumors

Artificial intelligence and machine learning are key to 3T Biosciences’ approach to identifying novel drug targets and engineering better, safer cancer immunotherapies. The Stanford spinout is now out of stealth with a $40 million Series A financing and a plan to reach the clinic within two years.

Ian Frazer Centre for Children's Immunotherapy Research aims to advance pediatric cancer care - Vimarsana News

Ian Frazer Centre for Children's Immunotherapy Research aims to advance pediatric cancer care

Australia's first dedicated children's immunotherapy center will investigate treatments to not only increase the survival of kids with cancer, but to also improve their ongoing quality of life.

Study paves new way to develop a predictive biomarker for TRAIL therapy - Vimarsana News

Study paves new way to develop a predictive biomarker for TRAIL therapy

A cytokine named TRAIL binds to TRAIL receptors and kills cancer cells, but not normal cells. Therefore, various anticancer drugs targeting TRAIL receptors have been developed and gained great attention as a promising cancer therapeutics, but a certain population of cancer patients does not respond to the therapy.

PET imaging could help measure the pharmacodynamic effects of using STING-activating drugs - Vimarsana News

PET imaging could help measure the pharmacodynamic effects of using STING-activating drugs

Stimulator of interferon genes, or STING, helps regulate immune activation. Thus, drugs that activate STING are being tested as a form of cancer immunotherapy and for treating certain infections.